Das Münchner Biotechunternehmen HMNC Brain Health hat in einer Series-B-Finanzierungsrunde 50 Millionen US-Dollar eingenommen. Medice führt die Runde mit knapp zehn Prozent des Kapitals an, unterstützt von prominenten Einzelpersonen.
Moderna-Chef Stéphane Bancel signalisiert Interesse an der Übernahme von Biontech-Produktionsstätten in Deutschland, die Biontech schließen möchte. Bancel betont die Notwendigkeit einer Partnerschaft mit der Bundesregierung und besseren Rahmenbedingungen für Investitionen.
Moderna-Chef Stéphane Bancel signalisiert Interesse an der Übernahme von Biontech-Produktionsstätten in Deutschland, die Biontech schließen möchte. Bancel nennt sinkende Umsätze als Grund für Biontechs Schließungspläne und betont die Notwendigkeit stabiler Rahmenbedingungen für Moderna-Investitionen.
Moderna prüft die Übernahme von Biontech-Produktionsanlagen in Deutschland, die der Konkurrent wegen gesunkener Nachfrage schließen will. Moderna-Chef Bancel sucht Gespräche mit der Bundesregierung über Investitionen und bessere Rahmenbedingungen.
Moderna erwägt die Übernahme von Biontech-Produktionsstätten in Deutschland, falls die Bundesregierung eine Partnerschaft eingeht. Biontech schließt Werke wegen sinkender Umsätze mit Covid-Impfstoffen und will sich auf Krebsforschung konzentrieren.
The IPO window for biotech companies is open, but strong firms may still opt for M&A with Big Pharma. Investors are selective, favoring 'best in class' assets. Deal values are increasing, with China emerging as a key player.
The biotech IPO market is showing signs of recovery, but top dealmakers at JPMorgan suggest strong companies may still opt for acquisition by Big Pharma. Investors are more selective, leading many biotechs to pursue dual-track strategies. This trend reflects a broader healthcare dealmaking rebound driven by Big Pharma's need to replenish pipelines.
The biotech IPO market is showing signs of life, but top dealmakers at JPMorgan suggest that strong companies are still more likely to be acquired by Big Pharma. Investors are more selective, leading many biotechs to pursue dual-track strategies.
A unique leather bag crafted from T. rex cells, using biotechnological methods to recreate dinosaur skin in a lab, is set to be auctioned in Paris with an estimated price exceeding $500,000.
Chinese biotech companies are pursuing global commercialization despite US regulatory barriers, leveraging cost advantages in markets like Europe. Insilico Medicine's Ren Feng highlighted the need for internationalization and the challenge of lacking overseas clinical teams, suggesting business development deals as a solution.
GSK acquires Nuvalent for $10.6B to bolster oncology pipeline with late-stage lung cancer treatments, aiming to offset future revenue drop from losing HIV medicine exclusivity.
Leading AI and biotech executives call on US Congress to mandate safety screening for synthetic DNA purchases, citing increased biosecurity risks due to rapid AI advancements.
New security footage shows Miami biotech executive Justin Zelin with Corey Hutterli days before Zelin's death. Hutterli is accused of murder after Zelin fell 25 floors. Defense claims Zelin had a psychotic break.
A bactéria Pseudomonas aeruginosa, comum no ambiente, levou ao recolhimento de um lote de água mineral Crystal e produtos da Ypê no Brasil. Embora inofensiva para pessoas saudáveis, representa risco para imunossuprimidos.
US-China geopolitical tensions may extend to biotechnology as Chinese firms secure record $60B in cross-border deals in Q1 2026, dominating global biotech deal-making. US policymakers express concern over capital fueling China's industry growth.
Le laboratoire pharmaceutique chinois BeOne présentera ses travaux sur des candidats médicaments contre divers cancers à l'Asco à Chicago. L'entreprise se distingue par sa stratégie de commercialisation directe de ses médicaments hors de Chine, notamment aux États-Unis, illustrant la montée en puissance des biotechs chinoises.
US lawmakers and investors are raising concerns about American pharmaceutical companies' increasing reliance on China for drug development, fearing a repeat of the rare earths scenario and prompting calls for national security restrictions on biotech investments in China.
Ivonescimab's phase three trial showed a 34% reduction in death risk for non-small cell lung cancer patients. Despite positive results, its shares dropped 1.86% in Hong Kong.
Airbus and Air France have been found guilty of involuntary manslaughter following the 2009 Rio-Paris crash, which resulted in the deaths of 228 people. This decision comes after years of legal proceedings.
Jeff Bezos downplays AI bubble concerns, stating long-term benefits outweigh risks and comparing the current AI boom to the 1990s biotech bubble. He also advocates for eliminating taxes for the bottom 50% of American earners.
Stefan Pfister, Leiter des Hopp-Kindertumorzentrums Heidelberg, entwickelt innovative Krebstherapien für Kinder. Die Auslegung deutscher Datenschutzregeln erschwert jedoch die internationale Zusammenarbeit und den Vergleich von Daten, was die Entwicklung von Behandlungen für seltene Kinderkrebserkrankungen behindert.
Christian Angermayer, a billionaire known for biotech and bitcoin, is launching the "Enhanced Games," which permits performance-enhancing drugs. He believes this is the future of sport, despite criticism from anti-doping authorities.
Biotech firm Imperagen secured £5 million in seed funding led by PXN Ventures to advance its AI and quantum physics-based enzyme engineering technology. The company aims to make enzyme development faster, more efficient, and cost-effective, with new CEO Guy Levy-Yurista at the helm.
Colossal Biosciences has successfully hatched 26 chickens using 3D-printed artificial eggs, a breakthrough they believe could aid in resurrecting extinct bird species like the dodo and moa.
